Search results for: vpag

Landmark deal reached on UK voluntary rebate schem...

Government, NHS, and Pharma Industry Unveil Successor to Voluntary Scheme for Branded Medicines Pric...

ABPI sets out new proposals in VPAG

ABPI announces new VPAG, which focuses on restoring the commercially competitive environment for lif...

Newer

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Email Address(Required)

Phone(Required)

This field is hidden when viewing the form

Job Title(Required)

Which category are you most interested in receiving content on?(Required)

Consent

I agree to be contacted with relevant content and news

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.

Get in touch

+41 4150 87573

contact@remapconsulting.com

Remap Consulting GmbH
Industriestrasse 47
Postfach 7461
6302 Zug
Switzerland

Remap Consulting UK Ltd
1F43, Mereside
Alderley Park
Cheshire
SK10 4TG

Services

Launch
Pricing
Training

Resources

Resource Library
Case Studies
Insights
News
Events

Company

Meet The Team
Join Our Team
Corporate Social Responsibility
Diversity, Equity and Inclusion
Contact

Design by Kensa Creative

MFN Policy Is Moving — Join the Conversation (Part II)

US Most Favoured Nation (MFN) policy continues to evolve.

Join our complimentary 30-minute Office Hours session to explore the latest developments and what they could mean for pricing, launch sequencing and global strategy.

Hosted by Paul Craddy & Nicole Lodowski

26 March 2026 | 2:30–3:00 PM GMT